-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Athira Pharma, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q2 2024.
- Athira Pharma, Inc. Depreciation for the quarter ending June 30, 2024 was $242K, a 0.82% decline year-over-year.
- Athira Pharma, Inc. Depreciation for the twelve months ending June 30, 2024 was $973K, a 2.42% increase year-over-year.
- Athira Pharma, Inc. annual Depreciation for 2023 was $969K, a 14.7% increase from 2022.
- Athira Pharma, Inc. annual Depreciation for 2022 was $845K, a 76.4% increase from 2021.
- Athira Pharma, Inc. annual Depreciation for 2021 was $479K, a 23850% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)